| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Dec―05 |
Male Hypogonadism After Recovery from Acute COVID-19 Infection: A
Prospective Observational Study |
Aravind Prasad, K. G Rashmi, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Mukta Wyawahare, R Anusuya, Dukhabandhu Naik |
| 2 |
[GO] |
2023―Apr―04 |
Association between prehospital blood glucose levels and outcomes in patients with COVID-19 infection: a retrospective cohort study |
Christophe Fehlmann, Laurent Suppan, Christophe Gaudet-Blavignac, Nadia. Elia, Karim Gariani |
| 3 |
[GO] |
2023―Mar―28 |
Metabolic and endocrine complications of long COVID-19: A review |
Thushari Bandara, Harshal A Deshmukh, Mohammed Abdalla, Thozhukat Sathyapalan |
| 4 |
[GO] |
2023―Jan―24 |
Glucometabolic perturbations in type 2 diabetes mellitus and coronavirus disease 2019: causes, consequences, and how to counter them using novel antidiabetic drugs |
Djordje Popovic, NIKOLAOS PAPANAS, Theocharis Koufakis, Kalliopi Kotsa, Wael Al Mahmeed, Khalid Al-Rasadi, et al. (+22) Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, A. Janez, Sanjay Kalra, Peter Kempler, Nitin Kapoor, Nader Lessan, Paulo Lotufo, Ali A Rizvi, Amirhossein Sahebkar, Raul D Santos, Anca Pantea Stoian, Peter P Toth, Vijay Viswanathan, Manfredi Rizzo |
| 5 |
[GO] |
2023―Jan―10 |
Fasting plasma glucose increase and Neutrophil to Lymphocyte Ratio (NLR) as risk predictors of clinical outcome of COVID-19 pneumonia in type 2 diabetes mellitus |
Vasileios Petrakis, Periklis Panagopoulos, Grigorios Trypsianis, Dimitrios Papazoglou, NIKOLAOS PAPANAS |
| 6 |
[GO] |
2022―Feb―19 |
COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic
Control in Adults with Type 1 and Type 2 Diabetes |
B Hartmann, S R Tittel, M Femerling, M. Pfeifer, S. Meyhöfer, K Lange, et al. (+4) S Milek, L Stemler, F Best, R W Holl |
| 7 |
[GO] |
2021―Nov―30 |
Glucose on Admission: Unfavourable Effects on Hospitalisation and
Outcomes in Type 2 Diabetes Mellitus Patients with COVID-19
Pneumonia |
Vasilios Petrakis, Periklis Panagopoulos, Grigorios Trypsianis, Dimitrios Papazoglou, Nikolaos Papanas |
| 8 |
[GO] |
2021―Aug―12 |
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity) |
Ibrahim Sahin, Cem Haymana, Tevfik Demir, Ibrahim Demirci, Ilker Tasci, Aysegul Atmaca, et al. (+12) Erman Cakal, Naim Ata, Rifat Emral, Ugur Unluturk, Derun Ertugrul, Serpil Salman, Mustafa Sahin, Selcuk Dagdelen, Osman Celik, Murat Caglayan, Ilhan Satman, Alper Sonmez |
| 9 |
[GO] |
2021―Jun―23 |
Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia |
Vasileios Petrakis, Grigorios Trypsianis, Periklis Panagopoulos, Dimitrios Papazoglou, Nikolaos Papanas |
| 10 |
[GO] |
2020―Dec―09 |
Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia |
Vasileios Petrakis, Periklis Panagopoulos, Dimitrios Papazoglou, Nikolaos Papanas |
| 11 |
[GO] |
2020―Nov―06 |
COVID-19 and Cardiovascular Comorbidities |
Dirk Müller-Wieland, Nikolaus Marx, Michael Dreher, Katharina Fritzen, Oliver Schnell |
| 12 |
[GO] |
2020―Sep―10 |
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to
Attempt? |
Stella Papachristou, Theano Penlioglou, Anca Pantea Stoian, Nikolaos Papanas |
| 13 |
[GO] |
2020―Aug―07 |
Therapeutic Patient Education for Adrenal Insufficiency under
COVID-19 Pandemic Conditions |
Tina Kienitz, Stefanie Hahner, Stephanie Burger-Stritt, Marcus Quinkler |
|
